September 2019

Events

Places Still Available for the ECI Workshop!

13 September 2019 /

The Early Career Investigator PMP Workshop in Cordoba is only a few weeks away, but we still have available places to attend the event. If you are interested in attending the workshop, you can click this link to sign up. The programme can be viewed here. See you there!

Read More

Health related quality of life is excellent and sustained at two decades after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in survivors of pseudomyxoma peritonei of appendiceal origin.(Read paper)
Recurrence after cytoreductive surgery and HIPEC for pseudomyxoma peritonei: A single-center retrospective cohort study.(Read paper)
Comparison of coagulation parameters associated with fibrinogen concentrate and cryoprecipitate for treatment of bleeding in patients undergoing cytoreductive surgery for pseudomyxoma peritonei: Subanalysis from a randomized, controlled phase 2 study.(Read paper)
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.(Read paper)
External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification.(Read paper)
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei.(Read paper)
Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation.(Read paper)
Pseudomyxoma Peritonei Arising from Urachal Mucinous Neoplasms: a Case Series and Updated Literature Review.(Read paper)
Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies-A report from the Indian HIPEC Registry.(Read paper)
Development and Validation of Nomograms to Predict Survival in Patients Undergoing Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin.(Read paper)